Trial details
Imaging biomarker for differentiating of radiation necrosis from tumour progression in brain metastasis treated with stereotactic radiosurgery
To find out more about this trial and your cancer treatment options, please speak with your doctor.
Trial short name: CEST Necrosis
Official title: Imaging biomarker for differentiating of radiation necrosis from tumour progression in brain metastasis treated with stereotactic radiosurgery
Principal Investigator: Dr. Hany Soliman
Cancer type: Central Nervous System
Cancer location: Central Nervous System
Disease stage: Early Cancer
Trial phase: Other
Intervention: no intervention
Registration #:
Contact e-mail: cancerclinicaltrials@sunnybrook.ca
